Silverarc Capital Management »

Surrozen shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 157k 22.60

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Kalvista Pharmaceuticals (KALV)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Dianthus Therapeutics (DNTH)
Kodiak Sciences (KOD)
Praxis Precision Medicines I Com New (PRAX)
Immunome (IMNM)
Fractyl Health (GUTS)
Uniqure Nv Call Call Option
Monte Rosa Therapeutics (GLUE)
Veracyte (VCYT)
Cg Oncology (CGON)

View all positions for Silverarc Capital Management

Top funds holding Surrozen

Stempoint Capital
VR Adviser
RA Capital Management
Braidwell
5AM Venture Management
Vanguard Group
Vivo Capital
Woodline Partners
Nantahala Capital Management
Longwood Capital Partners
Silverarc Capital Management
Regents of the University of California
Stonepine Capital Management
Millennium Management
Empery Asset Management

View all funds holding Surrozen